The feasibility of a second lumpectomy and breast brachytherapy for localized cancer in a breast previously treated with lumpectomy and radiation therapy for breast cancer

Manjeet Chadha, Sheldon M. Feldman, Susan Boolbol, Lin Wang, Louis B. Harrison

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Purpose: With accumulating evidence supporting partial-breast irradiation, we conducted a Phase I/II study to evaluate the role of a second conservative surgery and brachytherapy for patients presenting with a local recurrence/new primary in a breast who has previously undergone a lumpectomy and external radiation therapy for breast cancer. Methods and materials: Fifteen patients with a localized lesion in the breast have undergone a second lumpectomy and received low-dose-rate brachytherapy on protocol. The first 6 patients received a dose of 30 Gy. With no unacceptable acute toxicity observed, the brachytherapy dose was increased to 45 Gy. Three patients received adjuvant chemotherapy and 8 patients are on antiestrogen therapy. Results: The median time interval between the primary breast cancer diagnosis and the second cancer event in the ipsilateral breast is 94 months (range, 28-211). With a median followup of 36 months after brachytherapy, the 3-year Kaplan-Meier overall survival, local disease-free survival and mastectomy-free survival are 100% and 89%, respectively. There was no Grade 3/4 fibrosis or necrosis observed. All patients had baseline asymmetry due to the breast volume deficit from the second lumpectomy. With breast asymmetry as a given, the cosmetic result observed in all patients has been good to excellent. Conclusions: Early results suggest low-complication rates, high rate of local control and freedom from mastectomy. Additional studies are needed to establish whether a second lumpectomy and breast brachytherapy are an acceptable alternative to mastectomy for patients presenting with a localized cancer in a previously irradiated breast.

Original languageEnglish (US)
Pages (from-to)22-28
Number of pages7
JournalBrachytherapy
Volume7
Issue number1
DOIs
StatePublished - Jan 1 2008
Externally publishedYes

Fingerprint

Segmental Mastectomy
Brachytherapy
Breast
Radiotherapy
Breast Neoplasms
Neoplasms
Mastectomy
Estrogen Receptor Modulators
Survival
Second Primary Neoplasms
Adjuvant Chemotherapy
Cosmetics
Disease-Free Survival
Fibrosis
Necrosis
Recurrence

Keywords

  • Accelerated irradiation
  • Breast-conserving therapy
  • Partial-breast brachytherapy
  • Recurrent breast cancer
  • Second lumpectomy

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

The feasibility of a second lumpectomy and breast brachytherapy for localized cancer in a breast previously treated with lumpectomy and radiation therapy for breast cancer. / Chadha, Manjeet; Feldman, Sheldon M.; Boolbol, Susan; Wang, Lin; Harrison, Louis B.

In: Brachytherapy, Vol. 7, No. 1, 01.01.2008, p. 22-28.

Research output: Contribution to journalArticle

@article{a1d2d4c941654e4dacfc9132f622cae1,
title = "The feasibility of a second lumpectomy and breast brachytherapy for localized cancer in a breast previously treated with lumpectomy and radiation therapy for breast cancer",
abstract = "Purpose: With accumulating evidence supporting partial-breast irradiation, we conducted a Phase I/II study to evaluate the role of a second conservative surgery and brachytherapy for patients presenting with a local recurrence/new primary in a breast who has previously undergone a lumpectomy and external radiation therapy for breast cancer. Methods and materials: Fifteen patients with a localized lesion in the breast have undergone a second lumpectomy and received low-dose-rate brachytherapy on protocol. The first 6 patients received a dose of 30 Gy. With no unacceptable acute toxicity observed, the brachytherapy dose was increased to 45 Gy. Three patients received adjuvant chemotherapy and 8 patients are on antiestrogen therapy. Results: The median time interval between the primary breast cancer diagnosis and the second cancer event in the ipsilateral breast is 94 months (range, 28-211). With a median followup of 36 months after brachytherapy, the 3-year Kaplan-Meier overall survival, local disease-free survival and mastectomy-free survival are 100{\%} and 89{\%}, respectively. There was no Grade 3/4 fibrosis or necrosis observed. All patients had baseline asymmetry due to the breast volume deficit from the second lumpectomy. With breast asymmetry as a given, the cosmetic result observed in all patients has been good to excellent. Conclusions: Early results suggest low-complication rates, high rate of local control and freedom from mastectomy. Additional studies are needed to establish whether a second lumpectomy and breast brachytherapy are an acceptable alternative to mastectomy for patients presenting with a localized cancer in a previously irradiated breast.",
keywords = "Accelerated irradiation, Breast-conserving therapy, Partial-breast brachytherapy, Recurrent breast cancer, Second lumpectomy",
author = "Manjeet Chadha and Feldman, {Sheldon M.} and Susan Boolbol and Lin Wang and Harrison, {Louis B.}",
year = "2008",
month = "1",
day = "1",
doi = "10.1016/j.brachy.2007.10.006",
language = "English (US)",
volume = "7",
pages = "22--28",
journal = "Brachytherapy",
issn = "1538-4721",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - The feasibility of a second lumpectomy and breast brachytherapy for localized cancer in a breast previously treated with lumpectomy and radiation therapy for breast cancer

AU - Chadha, Manjeet

AU - Feldman, Sheldon M.

AU - Boolbol, Susan

AU - Wang, Lin

AU - Harrison, Louis B.

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Purpose: With accumulating evidence supporting partial-breast irradiation, we conducted a Phase I/II study to evaluate the role of a second conservative surgery and brachytherapy for patients presenting with a local recurrence/new primary in a breast who has previously undergone a lumpectomy and external radiation therapy for breast cancer. Methods and materials: Fifteen patients with a localized lesion in the breast have undergone a second lumpectomy and received low-dose-rate brachytherapy on protocol. The first 6 patients received a dose of 30 Gy. With no unacceptable acute toxicity observed, the brachytherapy dose was increased to 45 Gy. Three patients received adjuvant chemotherapy and 8 patients are on antiestrogen therapy. Results: The median time interval between the primary breast cancer diagnosis and the second cancer event in the ipsilateral breast is 94 months (range, 28-211). With a median followup of 36 months after brachytherapy, the 3-year Kaplan-Meier overall survival, local disease-free survival and mastectomy-free survival are 100% and 89%, respectively. There was no Grade 3/4 fibrosis or necrosis observed. All patients had baseline asymmetry due to the breast volume deficit from the second lumpectomy. With breast asymmetry as a given, the cosmetic result observed in all patients has been good to excellent. Conclusions: Early results suggest low-complication rates, high rate of local control and freedom from mastectomy. Additional studies are needed to establish whether a second lumpectomy and breast brachytherapy are an acceptable alternative to mastectomy for patients presenting with a localized cancer in a previously irradiated breast.

AB - Purpose: With accumulating evidence supporting partial-breast irradiation, we conducted a Phase I/II study to evaluate the role of a second conservative surgery and brachytherapy for patients presenting with a local recurrence/new primary in a breast who has previously undergone a lumpectomy and external radiation therapy for breast cancer. Methods and materials: Fifteen patients with a localized lesion in the breast have undergone a second lumpectomy and received low-dose-rate brachytherapy on protocol. The first 6 patients received a dose of 30 Gy. With no unacceptable acute toxicity observed, the brachytherapy dose was increased to 45 Gy. Three patients received adjuvant chemotherapy and 8 patients are on antiestrogen therapy. Results: The median time interval between the primary breast cancer diagnosis and the second cancer event in the ipsilateral breast is 94 months (range, 28-211). With a median followup of 36 months after brachytherapy, the 3-year Kaplan-Meier overall survival, local disease-free survival and mastectomy-free survival are 100% and 89%, respectively. There was no Grade 3/4 fibrosis or necrosis observed. All patients had baseline asymmetry due to the breast volume deficit from the second lumpectomy. With breast asymmetry as a given, the cosmetic result observed in all patients has been good to excellent. Conclusions: Early results suggest low-complication rates, high rate of local control and freedom from mastectomy. Additional studies are needed to establish whether a second lumpectomy and breast brachytherapy are an acceptable alternative to mastectomy for patients presenting with a localized cancer in a previously irradiated breast.

KW - Accelerated irradiation

KW - Breast-conserving therapy

KW - Partial-breast brachytherapy

KW - Recurrent breast cancer

KW - Second lumpectomy

UR - http://www.scopus.com/inward/record.url?scp=39649100016&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39649100016&partnerID=8YFLogxK

U2 - 10.1016/j.brachy.2007.10.006

DO - 10.1016/j.brachy.2007.10.006

M3 - Article

C2 - 18299110

AN - SCOPUS:39649100016

VL - 7

SP - 22

EP - 28

JO - Brachytherapy

JF - Brachytherapy

SN - 1538-4721

IS - 1

ER -